Effects of colesevelam HCl on hepatic insulin sensitivity, gluconeogenesis, glucose absorption and lipid synthesis in subjects with type 2 diabetes mellitus.

Trial Profile

Effects of colesevelam HCl on hepatic insulin sensitivity, gluconeogenesis, glucose absorption and lipid synthesis in subjects with type 2 diabetes mellitus.

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Oct 2012

At a glance

  • Drugs Colesevelam (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 02 Dec 2011 Results published in Diabetologia.
    • 02 Oct 2009 Results presented at the 45th Annual Meeting of the European Association for the Study of Diabetes
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top